90
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Significance of Oncotype DX 21-Gene Test and Expression of Long Non-Coding RNA MALAT1 in Early and Estrogen Receptor-Positive Breast Cancer Patients

, , , , , & show all
Pages 587-593 | Published online: 22 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Muhammad Tufail. (2023) The MALAT1-breast cancer interplay: insights and implications. Expert Review of Molecular Diagnostics 23:8, pages 665-678.
Read now
Jiulin Chen, Wei Zhou, Jingjing Chen, Haiyan Zhou, Zhangrong Chen, Xiaoyun Si, Bo Zhou, Fei Yan & Wei Li. (2023) Predictive Value of Serum Lncrna MALAT1 for the Recurrence of Persistent Atrial Fibrillation After Radiofrequency Ablation. Biomarkers in Medicine 17:8, pages 417-426.
Read now

Articles from other publishers (8)

Mohd Imran, Abida, Lina Eltaib, Muhammad Irfan Siddique, Mehnaz Kamal, Syed Mohammed Basheeruddin Asdaq, Neelam Singla, Marwan Al-Hajeili, Fatemah Abdulaziz Alhakami, Ahmed Farhan AlQarni, Altaf A. Abdulkhaliq & Ali A. Rabaan. (2024) Beyond the genome: MALAT1's role in advancing urologic cancer care. Pathology - Research and Practice 256, pages 155226.
Crossref
Monica Cantile, Margherita Cerrone, Maurizio Di Bonito, Pasquale Moccia, Maura Tracey, Gerardo Ferrara & Alfredo Budillon. (2023) Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review). International Journal of Oncology 64:1.
Crossref
Chen Huang, Min Deng, Dongliang Leng, Baoqing Sun, Peiyan Zheng & Xiaohua Douglas Zhang. (2023) MIRS: An AI scoring system for predicting the prognosis and therapy of breast cancer. iScience 26:11, pages 108322.
Crossref
Rafat Ali, Sorforaj A. Laskar, Nida Jamil Khan, Shadma Wahab & Mohammad Khalid. (2023) Non-coding RNA’s prevalence as biomarkers for prognostic, diagnostic, and clinical utility in breast cancer. Functional & Integrative Genomics 23:2.
Crossref
Cristian Arriaga-Canon, Laura Contreras-Espinosa, Sergio Aguilar-Villanueva, Enrique Bargalló-Rocha, José Antonio García-Gordillo, Paula Cabrera-Galeana, Clementina Castro-Hernández, Francisco Jiménez-Trejo & L. A. Herrera. (2023) The Clinical Utility of lncRNAs and Their Application as Molecular Biomarkers in Breast Cancer. International Journal of Molecular Sciences 24:8, pages 7426.
Crossref
Shahensha Shaik, Ha’reanna Campbell & Christopher Williams. (2022) NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype. BioMedInformatics 2:4, pages 680-691.
Crossref
Olivier Loudig, Megan I. Mitchell, Iddo Z. Ben-Dov, Christina Liu & Susan Fineberg. (2022) MiRNA expression deregulation correlates with the Oncotype DX® DCIS score. Breast Cancer Research 24:1.
Crossref
Athina N. Markou, Stavroula Smilkou, Emilia Tsaroucha & Evi Lianidou. (2021) The Effect of Genomic DNA Contamination on the Detection of Circulating Long Non-Coding RNAs: The Paradigm of MALAT1. Diagnostics 11:7, pages 1160.
Crossref